NewsON

NewsOFF

News

Website-Relaunch of Dr. Erkens Consulting Group

We have used the summer vacation and the current restrictions due to the Covid-19 pandemic to completely redesign our website and provide it with new content.

The website of the Dr. Erkens Consulting Group officially goes online on 03 September 2020, and in addition to corporate information about the Dr. Erkens Consulting Group and its range of services it offers many other features such as current information from the health industry, regular blog posts on topics relating to marketing and sales, and much more.

We have been supported in the creation of our new and completely responsive website by our longstanding partner be-sign.net.

Integrated Pharma-News at Dr. Erkens Consulting Group Website

As a strategy and consulting agency, we always need to be up to date. A large number of internet portals in the areas of healthcare, medicine, pharmaceuticals, biotech, medtech and life sciences are currently available. However, these areas are so large and evolve so rapidly that none of these portals alone can provide information about all the innovations. We therefore decided to provide links on our website to a number of selected news portals in order to keep you and us up to date with regard to indications, new diagnostic methods, therapies, market and company changes, trends, and much more.

Adress

Dr. Erkens Consulting Group
Industriestraße 13
64380 Roßdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de

Social

News

Dr. Erkens Consulting Group

Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020
Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020

Pharma Letter

Look back at pharma news in the week to May 7, 2021
Source: Pharma Letter Published on 2021-05-09
China NMPA conditional nod for pamiparib in ovarian cancer
Source: Pharma Letter Published on 2021-05-08
Merck & Co’s Organon spinoff billed as good news for all
Source: Pharma Letter Published on 2021-05-05
Oncimmune and Genostics Company part ways in China
Source: Pharma Letter Published on 2021-05-05
Positive top-line results for Sobi’s anakinra in COVID-19 pneumonia
Source: Pharma Letter Published on 2021-05-04

Pharma Relations

Siemens macht Mediaplus zur Global Lead Mediaagency
Source: Pharma Relations Published on 2022-12-02
fischerAppelt, relations holt den Etat der gesetzlichen Unfallversicherung VBG
Source: Pharma Relations Published on 2022-12-02
Ulrich Medical schließt strategische Kooperation mit GE Healthcare für die USA
Source: Pharma Relations Published on 2022-12-01
Investitionen in den Klimaschutz sind notwendig wie nie
Source: Pharma Relations Published on 2022-12-01
Mylife Media nutzt künftig Expertise und Netzwerk des Kindermedienspezialisten Blue Ocean
Source: Pharma Relations Published on 2022-11-30

Pharma Times

Merck KGaA’s arpraziquantel validated by European Medicines Agency
Source: Pharma Times Published on 2022-12-02
Healthcare leaders warn about unsustainable pressure on mental health services
Source: Pharma Times Published on 2022-12-02
Valneva and Pfizer report Lyme disease antibody data
Source: Pharma Times Published on 2022-12-01
Respiratory vaccination candidate tested in German hospitals
Source: Pharma Times Published on 2022-12-01
Eisai and Biogen present promising lecanemab study results
Source: Pharma Times Published on 2022-11-30

PZ online

Faktor-XI-Inhibitoren: Neues zur Antikoagulation
Source: PZ online Published on 2022-12-04
Impfkampagne verlängert: Corona-Impfungen in Apotheken werden verstetigt
Source: PZ online Published on 2022-12-03
»House of Pharma & Healthcare«: Die Sorge um die Lieferketten
Source: PZ online Published on 2022-12-01
US-Zulassung: Erste Gentherapie bei Hämophilie B
Source: PZ online Published on 2022-11-30
Interview S. Friedrich (Gedisa): »Das ist ein Zeichen für die europäischen Apothekenmärkte«
Source: PZ online Published on 2022-11-30

Our Place on Earth

BigMapDec

Kartenbild: OpenStreetMap, ODbL 1.0